Xcout Intel
Intervacc
Intervacc is a biotechnology company that develops modern animal health vaccines based on recombinant protein technology. The company serves the animal healthcare market with products like Strangvac, aimed at improving animal welfare and reducing the global reliance on antibiotics.
Subscribe to see Intervacc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Intervacc at a glance
Intervacc is a health care company headquartered in Sweden. Xcout tracks 5 named people at Intervacc, including Jan Persson (CFO).
Intervacc leadership
- Jan PerssonCFO
- Andrew WallerForskningschef
- Carl-Johan DalsgaardVD
- Anna-Carin LagerlöfFörsäljnings och marknadschef
- Astrid LarbergProgram manager
Get Intervacc's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Intervacc in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access